The XPOVIO brand, founded in 2015 (United States), from 5 sister brands and 2214 competing brands. XPOVIO is a brand of Karyopharm Therapeutics, listed on the stock exchange of New York. XPOVIO belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Karyopharm Therapeutics
(XPOVIO)
over 5 years*
USD 0.36